clover-biopharmaceuticals | ABS-CBN News

Clover says vaccine effective against COVID-19 variants

Zhuang Pinghui, South China Morning Post
Posted at Sep 23 03:17 PM

Trials show 79 percent efficacy against any severity of illness from the COVID-19 Delta variant, says Clover Biopharmaceuticals. Read more »

Sinovac clinical trial on elderly might start in May, says vaccine expert

ABS-CBN News
Updated as of Apr 13 11:05 PM

The Philippine government's vaccine expert said on Tuesday that following the start of 2 other COVID-19 vaccine clinical trials, Chinese company Sinovac might start its trial in May. Read more »

Vaccine czar nag-sorry, nagpaliwanag sa pagkaantala ng COVID-19 vaccines

ABS-CBN News
Posted at Feb 19 09:07 PM

Humingi ng pasensiya si vaccine czar Carlito Galvez Jr. sa pagkaantala ng pagdating ng COVID-19 vaccines. Read more »

COVID-19 vaccine clinical trial of Sinovac stalled due to overlapping sites with WHO trial

Kristine Sabillo, ABS-CBN News
Posted at Jan 25 08:44 PM

None of the three COVID-19 vaccine developers that were given approval to run clinical trials in the Philippines have started, the Department of Health said Monday. Read more »

EUA ng vaccine provider maaaring bawiin, baguhin: FDA

ABS-CBN News
Posted at Jan 19 07:40 PM

Ano mang oras ay maaaring bawiin ang emergency use authorization na ibinigay sa kompanya ng bakuna, ayon sa FDA.  Read more »

FDA approves Clover Biopharmaceutical’s clinical trial application for COVID-19 vaccine

Kristine Sabillo, ABS-CBN News
Updated as of Jan 08 09:08 PM

MANILA—The Food and Drug Administration of the Philippines approved on Friday Clover Biopharmaceuticals’ application for its COVID-19 vaccine trial in the Philippines. Read more »

Galvez: Walang nagpabaya sa vaccine negotiations

ABS-CBN News
Posted at Dec 21 06:39 PM

Iginiit ni vaccine czar Carlito Galvez na walang nagpabaya sa pakikipag-negosasyon ng gobyerno sa iba-ibang pharmaceutical companies para matiyak na makakakuha ang Pilipinas ng COVID-19 vaccine. Read more »

2 COVID-19 vaccines pass pre-evaluation, sent to FDA for clinical trial application— DOH

Kristine Sabillo, ABS-CBN News
Updated as of Dec 11 01:40 PM

MANILA — The Department of Health's vaccine experts panel (VEP) and ethics review board have approved clinical trial applications of two COVID-19 vaccines, clearing the way for final evaluation by the Food and Drug Administration, a health official said yesterday.   Read more »

3 COVID-19 vaccine manufacturers lusot na sa ethics review

ABS-CBN News
Updated as of Dec 07 07:49 PM

Lusot na ang 3 manufacturers ng COVID-19 vaccine sa ethics review board ng bansa at sasailalim naman sa FDA evaluation. Read more »

3 vaccine makers hurdle PH’s ethics review; Moderna, Pfizer consider application — DOH

Kristine Sabillo, ABS-CBN News
Posted at Dec 07 12:41 PM

Three COVID-19 vaccine makers seeking to run clinical trials in the Philippines passed the country's ethics review board, one of the requirements needed before undergoing evaluation by the Food and Drug Administration, an official said Monday.   Read more »

AstraZeneca, Janssen nearing initial clearance by PH COVID-19 vaccine expert panel

Kristine Sabillo, ABS-CBN News
Updated as of Dec 04 01:29 PM

MANILA — The vaccine expert panel of the Philippines on Friday said that two vaccine developers might soon be given initial clearance for their proposed clinical trials in the country.   Read more »

Clinical trials of 2 Chinese COVID-19 vaccines may start yearend or early 2021— DOST

ABS-CBN News
Updated as of Nov 27 02:47 PM

MANILA — The Department of Science and Technology estimates that the Philippines might start its COVID-19 vaccine clinical trials with two vaccine developers by the end of 2020 or the start of next year. Read more »

Coronavirus: international funding boost for Chinese vaccine maker Clover

Simone McCarthy, South China Morning Post
Posted at Nov 04 03:03 PM

The Coalition for Epidemic Preparedness Innovations earmarks millions of dollars for the Chengdu-based firm to advance its candidate to next phase of trials. The company also plans to use money to scale up manufacturing of doses. Read more »